Wolf M - Search Results

1

Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertension.

Veyradier A, Nishikubo T, Humbert M, Wolf M, Sitbon O, Simonneau G, Girma JP, Meyer D. Veyradier A, et al. Among authors: wolf m. Circulation. 2000 Nov 14;102(20):2460-2. doi: 10.1161/01.cir.102.20.2460. Circulation. 2000. PMID: 11076816 Clinical Trial.

2

[Evaluation of a new automated method for von Willebrand factor antigen measurement: the STA-Liatest vWF].

Veyradier A, Fressinaud E, Sigaud M, Wolf M, Meyer D. Veyradier A, et al. Among authors: wolf m. Ann Biol Clin (Paris). 1999 May;57(3):364-8. Ann Biol Clin (Paris). 1999. PMID: 10377492 Free article. French. No abstract available.

3

Thrombotic risk factors in pulmonary hypertension.

Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, Simonneau G. Wolf M, et al. Eur Respir J. 2000 Feb;15(2):395-9. doi: 10.1034/j.1399-3003.2000.15b28.x. Eur Respir J. 2000. PMID: 10706510 Free article.

4

Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.

Veyradier A, Balian A, Wolf M, Giraud V, Montembault S, Obert B, Dagher I, Chaput JC, Meyer D, Naveau S. Veyradier A, et al. Among authors: wolf m. Gastroenterology. 2001 Feb;120(2):346-53. doi: 10.1053/gast.2001.21204. Gastroenterology. 2001. PMID: 11159874

5

Plasminogen activation by blood monocytes and alveolar macrophages in primary pulmonary hypertension.

Martin I, Humbert M, Marfaing-Koka A, Capron F, Wolf M, Meyer D, Simonneau G, Anglés-Cano E. Martin I, et al. Among authors: wolf m. Blood Coagul Fibrinolysis. 2002 Jul;13(5):417-22. doi: 10.1097/00001721-200207000-00006. Blood Coagul Fibrinolysis. 2002. PMID: 12138369

6

BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.

Humbert M, Deng Z, Simonneau G, Barst RJ, Sitbon O, Wolf M, Cuervo N, Moore KJ, Hodge SE, Knowles JA, Morse JH. Humbert M, et al. Among authors: wolf m. Eur Respir J. 2002 Sep;20(3):518-23. doi: 10.1183/09031936.02.01762002. Eur Respir J. 2002. PMID: 12358323 Free article.

7

Total deficiency of specific von Willebrand factor-cleaving protease and recovery following plasma therapy in one patient with hemolytic-uremic syndrome.

Veyradier A, Brivet F, Wolf M, Boyer-Neumann C, Obert B, Girma JP, Meyer D. Veyradier A, et al. Among authors: wolf m. Hematol J. 2001;2(5):352-4. doi: 10.1038/sj.thj.6200126. Hematol J. 2001. PMID: 11920271 No abstract available.

8

Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.

Veyradier A, Caron C, Ternisien C, Wolf M, Trossaert M, Fressinaud E, Goudemand J. Veyradier A, et al. Among authors: wolf m. Haemophilia. 2011 Nov;17(6):944-51. doi: 10.1111/j.1365-2516.2011.02499.x. Epub 2011 Mar 3. Haemophilia. 2011. PMID: 21371195

9

Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia.

Marfaing-Koka A, Wolf M, Boyer-Neumann C, Meyer D, Odievre M, Labrune P. Marfaing-Koka A, et al. Among authors: wolf m. J Pediatr Gastroenterol Nutr. 2003 Nov;37(5):566-70. doi: 10.1097/00005176-200311000-00011. J Pediatr Gastroenterol Nutr. 2003. PMID: 14581798

10

Continuous infusion of prostacyclin decreases plasma levels of t-PA and PAI-1 in primary pulmonary hypertension.

Boyer-Neumann C, Brenot F, Wolf M, Peynaud-Debayle E, Duroux P, Meyer D, Anglés-Cano E, Simonneau G. Boyer-Neumann C, et al. Among authors: wolf m. Thromb Haemost. 1995 Apr;73(4):735-6. Thromb Haemost. 1995. PMID: 7495094 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,955 results

Search Page

Filters